EUCTR2007-000885-20-NL进行中（未招募）1 期
Open label study to establish the efficacy of intravenous loading doses of Ibandronate 6 mg in patients with lung cancer and skeletal metastased experiencing moderate to severe bone pain.
academic hospital Maastricht0 个研究点目标入组 53 人开始时间: 2007年5月11日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with Malignant Bone Disease due to histology of cytology confirmed NSCLC.
- •MBD confirmed by bone scintigraphy, MRI, CT-scan, PET-scan or X-ray.
- •Mean bone pain score equal to or higher than 5.
- •Bone pain must correspond to areas of metastases on bone scinthigraphy, MRI, CT-scan, PET-scan of X-ray.
- •The use of at lease a NSAID or a weak opioid based on the WHO analgesic ladder step 2.
- •Age above 18 years.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Other active malignancies.
- •Nursing mothers.
- •Bone radiotherapy in the preceding 4 weeks
研究者
相似试验
已完成
不适用
Open label study to establish the efficacy of intravenous loading doses of Ibandronate 6 mg in patients with lung cancer and skeletal metastases experiencing moderate to severe bone pain: NVALT 9.on small cell lung cancer (NSCLC)NL-OMON19953VALT-oncology53
已完成
不适用
Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin) for intraocular neovascular disease and macular edemaOphthalmic neovascular disease Diabetic retinopathy Retinal vein occlusionJPRN-UMIN000014338Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine3,000
进行中（未招募）
1 期
Investigation on the effect and tolerability of erenumab in posttraumatic headachePost-traumatic headacheMedDRA version: 20.0Level: LLTClassification code 10019222Term: Headache post-traumaticSystem Organ Class: 100000004852EUCTR2018-003943-46-DKDanish Headache Center100
进行中（未招募）
1 期
An open label study to evaluate the efficacy and tolerability of erenumab in the management of persistent redness and flushing in rosacea - STOP ROS StudyEUCTR2019-003971-20-DKRigshospitalet Glostrup30
已完成
不适用
A randomised open label trial to assess the efficacy, safety, and pharmacokinetic parameters of a fixed dose formulation of artesunate-mefloquine and standard dose artesunate and mefloquine as loose tablets for treatment of uncomplicated falciparum malaria (Thailand)Infections and InfestationsMalariaISRCTN24192353Drugs for Neglected Diseases initiative (DNDi) (Switzerland)50